Disease | lung cancer |
Phenotype | C0032226|pleural disease |
Sentences | 3 |
PubMedID- 21552017 | Aim: the aim of this study was to assess the utility of dual-time-point f-18 fluorodeoxyglucose positron emission tomography (f-18 fdg pet) in differentiating benign from malignant pleural disease, in patients with non-small-cell lung cancer. |
PubMedID- 21616674 | Objectives: the prognosis of non-small-cell lung cancer (nsclc) patients with malignant pleural disease (mpd), characterized by malignant pleural effusion and/or malignant pleural nodules, is reported to be poor, and patients with mpd are generally not subjected to surgery. |
PubMedID- 21697244 | pleural disease in lung cancer can be benign or malignant with the latter carrying a grave prognosis. |
Page: 1